Please find enclosed the Newspaper Publication of Financial Results for the quarter and year ended 31st March 2026
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma Ltd has submitted its newspaper publication of financial results for the quarter and year ended 31st March 2026, as required under SEBI Listing Regulations (Regulation 47). The results were published on 6th May 2026 in the Mumbai editions of Business Standard and Navakal newspapers. The filing serves as a compliance intimation to BSE (Scrip Code: 532331) and NSE (AJANTPHARM EQ), confirming that the company has fulfilled its obligation to make financial results publicly available through newspapers. No specific financial figures or commentary are included in this cover letter; the detailed results are contained in the published newspaper clippings.
Routine regulatory compliance filing with no new material information for investors. The filing confirms Ajanta Pharma has met its mandatory newspaper publication requirement for Q4 and full-year FY 2026 results.